Chongqing Genrix Biopharmaceutical Co. Ltd. A

SHG:688443 China Biotechnology

Market Cap

$1.33 Billion

CN¥9.79 Billion CNY

Market Cap Rank

#11209 Global

#2600 in China

Share Price

CN¥26.70

Change (1 day)

+0.79%

52-Week Range

CN¥23.89 - CN¥37.02

All Time High

CN¥45.06

Chongqing Genrix Biopharmaceutical Co. Ltd. A - Asset Resilience Ratio

Latest as of June 2025: 22.86%

Chongqing Genrix Biopharmaceutical Co. Ltd. A (688443) has an Asset Resilience Ratio of 22.86% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥712.50 Million

Cash + Short-term Investments

Total Assets

CN¥3.12 Billion

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Chongqing Genrix Biopharmaceutical Co. Ltd. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Chongqing Genrix Biopharmaceutical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥712.50 Million	22.86%
Total Liquid Assets	CN¥712.50 Million	22.86%

Asset Resilience Insights

Good Liquidity Position: Chongqing Genrix Biopharmaceutical Co. Ltd. A maintains a healthy 22.86% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.